scholarly journals Distal gastric tube resection with preservation of the right gastroepiploic artery for gastric tube cancer: a case report

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Kohei Tajima ◽  
Hideo Shimada ◽  
Takayuki Nishi ◽  
Yutaro Kamei ◽  
Kazuo Koyanagi ◽  
...  

Abstract Background The incidence of gastric tube cancer is increasing because of improved survival rates in patients with esophageal cancer treated by esophagectomy. Total resection of the gastric tube is expected to be highly curative, but it is associated with a higher risk of severe postoperative complications. Herein we report a case of early gastric tube cancer that was successfully treated by distal gastric tube resection with preservation of the right gastroepiploic artery (RGEA). Case presentation An 82-year-old man was diagnosed as having gastric tube cancer, B-12-O, Type 0-IIc, T1b, N0, M0, cStage IA (Japanese Classification of Gastric Carcinoma). Upper gastrointestinal endoscopy showed a Type 0-IIc lesion measuring 30 mm in length in the lower part of the gastric tube, and histopathological examination of biopsy specimens revealed the features of poorly differentiated adenocarcinoma. The primary lesion could not be identified by computed tomography, and there was no obvious lymph node metastasis or distant metastasis. Considering that total resection of the gastric tube would have been highly invasive and that the gastric tube cancer was at a relatively early stage, we performed distal gastric tube resection with preservation of the RGEA. The postoperative course was uneventful, and the patient was discharged on postoperative day 12. There has been no recurrence during the 17 months of follow-up. Conclusion We successfully treated a patient with gastric tube cancer by distal gastric tube resection with preservation of the RGEA. This treatment strategy may be acceptable for patients with early gastric tube cancer without lymph node metastasis, considering the balance between the surgical invasiveness and curability of the tumor.

2021 ◽  
Author(s):  
Xiaoxiao Zhong ◽  
Fengjiao Ding ◽  
Liyuan Qian ◽  
Wei Wu ◽  
Yanguang Wen ◽  
...  

Abstract Background: Contralateral neck lymph node metastasis is rare for primary breast cancer. Its clinical stage and treatment principles are lack of authoritative guidelines. A 30-year-old breast cancer patient with contralateral neck lymph node metastasis is presented. The clinical treatment is discussed combined with current research.Case presentation: A 30-year-old woman presented with a right breast mass for 5 months and left neck lymph node enlargement for 5 days. The mammography showed a 33mm*14.3mm mass in the inner quadrant of right breast. The ultrasound showed several hypoechoic nodules on the left side of the neck. Rapid intraoperative pathological examination diagnosed right breast malignant tumor and poorly differentiated carcinoma of the left cervical lymph nodes. Then the right mastectomy was performed immediately. The patient was scheduled to administer chemotherapy, molecular targeted therapy, radiotherapy and endocrinotherapy after operation. The long-term efficacy remains to be seen.Conclusion: The infrequent presentation of breast cancer with metastasis to the contralateral neck lymph node can be challenged for standard therapies.


2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 45-45
Author(s):  
Simone Giacopuzzi ◽  
Jacopo Weindelmayer ◽  
Giovanni De Manzoni

Abstract Description Extended thoracoscopic lymphadenectomy is not common practice in Western countries in patients with adenocarcinoma of the esophagogastric junction. In this video we present a case of a patient with siewert I adenocarcinoma with lymph node metastasis to the right recurrent laryngeal nerve not treated with neoadjuvant therapy, due to comorbidity. The operation was: extended thoracoscopic en-block lymph node dissection. video will be edited in a more rigorous manner Disclosure All authors have declared no conflicts of interest.


1992 ◽  
Vol 45 (6) ◽  
pp. 823-828
Author(s):  
S. Yamaguchi ◽  
S. Ohki ◽  
T. Jo ◽  
S. Imai ◽  
K. Matsuo ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-3
Author(s):  
Joji Kawabe ◽  
Shigeaki Higashiyama ◽  
Mitsuharu Sougawa ◽  
Atsushi Yoshida ◽  
Kohei Kotani ◽  
...  

A woman in her 60s presented with a recurrent lymph node metastasis from a papillary thyroid carcinoma in the right parapharyngeal space. She had already undergone total thyroidectomy, five resections for cervical lymph node metastases, and right carotid rebuilding. Surgical resection of the current metastasis was impossible. 131I-radioiodine therapy (RIT) with 3.7 GBq 131I was not effective; therefore, stereotactic radiation therapy (SRT) using a CyberKnife radiotherapy system was scheduled. The prescription dose was 21 Gy, and a dose covering 95% of the planning target volume (PTV) in three fractions was administered. The PTV was 4,790 mm3. Follow-up magnetic resonance imaging conducted 3 and 12 months after the SRT demonstrated a remarkable and gradual reduction of the recurrent lymph node metastasis in the right parapharyngeal space and no evidence of recurrence. For multidisciplinary therapy of unresectable and/or RIT unresponsive locoregional lymph node metastases and recurrences of DTC, SRT using the CyberKnife system should be considered.


2020 ◽  
Author(s):  
Jianbo Li ◽  
Gaofei He ◽  
Yifan Tong ◽  
Li Tao ◽  
Lei Xie ◽  
...  

Background: Papillary thyroid carcinoma (PTC) can frequently metastasize to the cervical lymph node, especially in the central compartment. Some surgeons believe that dissection posterior to the right recurrent laryngeal nerve lymph node (PRRLN-LN) is unnecessary because of the low metastasis rate and high complication risk. However, persistent metastatic lymph nodes may have a higher recurrence rate, surgical risk, and complications. Thus, it is important to distinguish patients who require PRRLN-LN dissection. The aim of this study was to identify the risk factors for PRRLN-LN metastasis (LN-prRLN), and to establish a scoring system, to help determine whether PRRLN-LN dissection is required in PTC patients. Methods: The study comprised 821 patients with primary PTC in the right or both lobes who had undergone right lobectomy or total thyroidectomy with only right, or bilateral central compartment dissection with/without lateral neck dissection, between January 2010 and June 2016 in our institution. Participants were randomly allocated to development and validation cohorts in a 2:1 ratio. A nomogram-based predictive model for LN-prRLN was established based on the risk factors identified in the development cohort. Results: LN-prRLN was diagnosed pathologically in 15.1% (124/821) of patients from the entire cohort. Multivariate analysis identified age (odds ratio [OR] 0.964, 95% confidence interval [CI] 0.945–0.983; P<0.001), tumor size (OR 1.536, 95%CI 1.135–2.079; P=0.005), extrathyroidal extension (OR 2.271, 95%CI 1.368–3.770; P=0.002), clinically-involved right central compartment lymph node metastasis (OR 1.643, 95%CI 1.055–2.559; P=0.028), and right lateral lymph node metastasis (OR 4.271, 95%CI 2.325–7.844; P<0.001) as predictors of LN-prRLN. A risk model was established and well validated. Calibration curves to evaluate the nomogram in both the development and validation cohorts revealed a C-index of 0.756±0.058 and 0.745±0.042, respectively. Conclusions: Our scoring system may be useful for helping surgeons to decide which patients should undergo dissection of the PRRLN-LN. Abbreviations: ATA = American Thyroid Association; CCD = Central compartment dissection; CI = Confidence interval; C-index = The concordance index; ETE = Extrathyroidal extension; FNA = Fine-needle aspiration; LNM = Lymph node metastasis; LN-prRLN = Posterior to the right recurrent laryngeal nerve lymph node metastasis; OR = Odds ratio; PRRLN-LN = Posterior to the right recurrent laryngeal nerve lymph node; PTC = Papillary thyroid carcinoma; RLN = Recurrent laryngeal nerve.


Surgery Today ◽  
2001 ◽  
Vol 31 (3) ◽  
pp. 238-241 ◽  
Author(s):  
Kazumitsu Ueda ◽  
Hiroyuki Nagayama ◽  
Kazuhiro Narita ◽  
Mitsuo Kusano ◽  
Masahiro Aiba ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document